Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes
| Autor: | Kevin C. Zorn, Pierre-Alain Hueber, Neil Barber, Alexis E. Te, Amr M. Emara, Matthew P. Rutman, Quoc-Dien Trinh, Hugo Lavigueur-Blouin, Bilal Chughtai, Vincent Misraï, Roger Valdivieso, Marc Bienz, Ravi Munver |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
medicine.medical_specialty Urology Prostatic Hyperplasia Endosonography Prostate medicine Humans Aged Retrospective Studies Aged 80 and over business.industry Rectum Transurethral Resection of Prostate Equipment Design Organ Size Hyperplasia medicine.disease Prostate size Prostate-specific antigen Treatment Outcome medicine.anatomical_structure Multicenter study Cohort Quality of Life International Prostate Symptom Score Photoselective vaporization Laser Therapy Volatilization business |
| Zdroj: | Journal of Urology. 194:462-469 |
| ISSN: | 1527-3792 0022-5347 |
| Popis: | We evaluated photoselective vaporization of the prostate using the GreenLight™ XPS™ 180 W system for benign prostatic hyperplasia treatment in a large multi-institutional cohort at 2 years. We particularly examined safety, outcomes and the re-treatment rate in larger prostates, defined as a prostate volume of 80 cc or greater, to assess the potential of photoselective vaporization of the prostate as a size independent procedure.A total of 1,196 patients were treated at 6 international centers in Canada, the United States, France and England. All parameters were collected retrospectively, including complications, I-PSS, maximum urinary flow rate, post-void residual urine, prostate volume, prostate specific antigen and the endoscopic re-intervention rate. Subgroup stratified comparative analysis was performed according to preoperative prostate volume less than 80 vs 80 cc or greater on transrectal ultrasound.Median prostate size was 50 cc in 387 patients and 108 cc in 741 in the prostate volume groups less than 80 and 80 cc or greater, respectively. The rate of conversion to transurethral prostate resection was significantly higher in the 80 cc or greater group than in the less than 80 cc group (8.4% vs 0.6%, p0.01). I-PSS, quality of life score, maximum urinary flow rate and post-void residual urine were significantly improved compared to baseline at 6, 12 and 24 months of followup without significant differences between the prostate size groups. The re-treatment rate at 2 years reported in 5 of 411 patients was associated with the delivery of decreased energy density (2.1 vs 4.4 kJ/cc) in the group without re-treatment.Photoselective vaporization of the prostate using the XPS 180 W system is safe and efficacious, providing durable improvement in functional outcomes at 2 years independent of prostate size when treated with sufficient energy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|